N-acetylcysteine (NAC) nebulizer therapy is effective and safe as a short-term (12-week) treatment for reducing phlegm in chronic obstructive pulmonary disease (COPD), according to study findings ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

Some are backed by preliminary research while others aren't. However, NAC has the unusual distinction of being approved by the Food and Drug Administration (FDA) for some uses, including treatment for ...

Background: N-acetyl cysteine (NAC) appears promising as a treatment in patients with substance use disorder (SUD) as it helps rebalance glutamate levels in the central nervous system (CNS). Basal ...

N-acetylcysteine (NAC) failed to eradicate Mycobacterium tuberculosis infection, but it did appear to improve lung function in patients with moderate or far-advanced disease, according to a phase ...

In the UK, a 20 h intravenous N-acetylcysteine (NAC) regimen is the standard antidote for significant acute paracetamol poisoning. In the USA, although the Food and Drug Administration approved the ...

N-acetylcysteine (NAC) is used to treat various types of bowel obstruction in children but evidence of efficacy is lacking. The formulations used are unlicensed and the dosing information in the ...

Bucillamine (N- (mercapto-2-methylpropionyl)-l-cysteine) has a well-known safety profile and is prescribed in the treatment of rheumatoid arthritis in Japan and South Korea for over 30 years.

L-methylfolate calcium (Metafolin) 6mg, Algae-S powder 90.314mg, methylcobalamin 2mg, N-acetylcysteine 600mg; caplets. Avoid if renal stones occur. Do not administer to critically ill patients.

Patients' disease characteristics and demographic data at screening (T0) are reported in Table 1. At the screening visit (T0), CRP levels were higher than normal (=0.5 mg/dL) in 81 (66.4% ...